$CYAN
CYANOTECH CORP Stock $cyan

$cyan Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923023314 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$6.373M	$5.146M
YoY Change	23.05%	-23.38%
Cost Of Revenue	$4.285M	$3.614M
YoY Change	26.44%	-17.83%
Gross Profit	$2.088M	$1.532M
YoY Change	16.65%	-33.91%
Gross Profit Margin	32.76%	29.77%
Selling, General & Admin	$2.545M	$2.550M
YoY Change	5.12%	2.12%
% of Gross Profit	121.89%	166.45%
Research & Development	$175.0K	$191.0K
YoY Change	-15.05%	-22.36%
% of Gross Profit	8.38%	12.47%
Depreciation & Amortization	$404.0K	$407.0K
YoY Change	-3.12%	-2.4%
% of Gross Profit	19.35%	26.57%
Operating Expenses	$2.720M	$2.741M
YoY Change	3.54%	-0.07%
Operating Profit	-$632.0K	-$1.209M
YoY Change	-24.49%	184.47%
Interest Expense	$163.0K	$160.0K
YoY Change	58.25%	263.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$795.0K	-$1.369M
YoY Change	-15.43%	191.9%
Income Tax	$2.000K	$0.00
% Of Pretax Income
Net Earnings	-$797.0K	-$1.369M
YoY Change	-15.21%	190.04%
Net Earnings / Revenue	-12.51%	-26.6%
Basic Earnings Per Share	-$0.13	-$0.22
Diluted Earnings Per Share	-$0.13	-$0.22
COMMON SHARES
Basic Shares Outstanding	6.308M	6.291M
Diluted Shares Outstanding	6.366M	6.290M

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.240M	$648.0K
YoY Change	227.18%	-12.08%
Cash & Equivalents	$1.236M	$648.0K
Short-Term Investments
Other Short-Term Assets	$430.0K	$378.0K
YoY Change	20.79%	-2.07%
Inventory	$9.591M	$10.51M
Prepaid Expenses
Receivables	$1.430M	$1.794M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$12.69M	$13.33M
YoY Change	-15.1%	-11.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.78M	$11.07M
YoY Change	-8.27%	-7.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$88.00K	$85.00K
YoY Change	-4.35%	-10.53%
Total Long-Term Assets	$15.40M	$15.81M
YoY Change	-0.1%	0.72%
TOTAL ASSETS
Total Short-Term Assets	$12.69M	$13.33M
Total Long-Term Assets	$15.40M	$15.81M
Total Assets	$28.08M	$29.13M
YoY Change	-7.48%	-5.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.392M	$1.721M
YoY Change	-9.84%	-10.69%
Accrued Expenses	$897.0K	$821.0K
YoY Change	-16.79%	-38.59%
Deferred Revenue	$127.0K	$77.00K
YoY Change	38.04%	-2.53%
Short-Term Debt	$2.480M	$2.520M
YoY Change	90.77%
Long-Term Debt Due	$5.737M	$5.833M
YoY Change	263.79%	1411.14%
Total Short-Term Liabilities	$8.659M	$8.946M
YoY Change	88.85%	119.64%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M
YoY Change	-76.26%	-76.6%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$1.000M	$1.000M
YoY Change	-76.29%	-76.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.659M	$8.946M
Total Long-Term Liabilities	$1.000M	$1.000M
Total Liabilities	$13.68M	$14.09M
YoY Change	13.33%	20.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.80M	-$19.00M
YoY Change	26.87%	29.57%
Common Stock	$129.0K	$126.0K
YoY Change	3.2%	1.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.41M	$15.04M
YoY Change
Total Liabilities & Shareholders Equity	$28.08M	$29.13M
YoY Change	-7.48%	-5.16%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$797.0K	-$1.369M
YoY Change	-15.21%	190.04%
Depreciation, Depletion And Amortization	$404.0K	$407.0K
YoY Change	-3.12%	-2.4%
Cash From Operating Activities	$840.0K	-$596.0K
YoY Change	-172.35%	-54.12%
INVESTING ACTIVITIES
Capital Expenditures	$140.0K	$150.0K
YoY Change	-144.59%	-139.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$140.0K	-$150.0K
YoY Change	-55.41%	-60.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-110.0K	$420.0K
YoY Change	-109.85%	-337.29%
NET CHANGE
Cash From Operating Activities	840.0K	-$596.0K
Cash From Investing Activities	-140.0K	-$150.0K
Cash From Financing Activities	-110.0K	$420.0K
Net Change In Cash	590.0K	-$326.0K
YoY Change	-264.8%	-82.4%
FREE CASH FLOW
Cash From Operating Activities	$840.0K	-$596.0K
Capital Expenditures	$140.0K	$150.0K
Free Cash Flow	$700.0K	-$746.0K
YoY Change	-182.64%	-19.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	64000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6291086
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6291086
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6271971
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6271971
CY2023Q2	cyan	Number Of Shareholder Approved Sharebased Compensation Plans NumberOfShareholderApprovedSharebasedCompensationPlans	2	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	0-14602
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1206026
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	73-4460 Queen Kaahumanu Hwy. #102
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Kailua-Kona
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	HI
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	96740
CY2023Q2	dei	City Area Code CityAreaCode	808
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	326-1353
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.02 par value per share
CY2023Q2	dei	Trading Symbol TradingSymbol	CYAN
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6308010
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	648000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	974000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1794000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1331000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	10506000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	10707000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	378000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	484000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	13326000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	13496000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11065000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11366000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4656000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4776000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	85000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	90000	usd
CY2023Q2	us-gaap	Assets Assets	29132000	usd
CY2023Q1	us-gaap	Assets Assets	29728000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1721000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1021000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	821000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1101000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	77000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	89000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	494000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483000	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1770000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1540000	usd
CY2023Q2	cyan	Lines Of Credit Related Party Current LinesOfCreditRelatedPartyCurrent	750000	usd
CY2023Q1	cyan	Lines Of Credit Related Party Current LinesOfCreditRelatedPartyCurrent	500000	usd
CY2023Q2	cyan	Longterm Debt Current Maturities Excluding Line Of Credit Current LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent	3313000	usd
CY2023Q1	cyan	Longterm Debt Current Maturities Excluding Line Of Credit Current LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent	3369000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8946000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8103000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4146000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4275000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	14092000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	13381000	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	126000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	125000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33917000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33856000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19003000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17634000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15040000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16347000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29132000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29728000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5146000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6716000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3614000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4398000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1532000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2318000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1274000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1329000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1276000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1168000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	191000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	246000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2741000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2743000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1209000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-425000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	160000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	44000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1369000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-469000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1369000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-472000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6290000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6204000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6290000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6204000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16347000	usd
CY2023Q2	cyan	Stock Issued During Period Value Director Stockgrants StockIssuedDuringPeriodValueDirectorStockgrants	16000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-1000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	47000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1369000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15040000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	19487000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-3000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-472000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	19034000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1369000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-472000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	407000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	417000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	10000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	120000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	105000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	47000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	22000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	474000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-463000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-201000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1233000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-104000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-168000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	744000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-509000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-264000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-75000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-12000	usd
CY2022Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-85000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-118000	usd
CY2022Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-110000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-3000	usd
CY2022Q2	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-3000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-596000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1299000	usd
CY2023Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	150000	usd
CY2022Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	376000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-150000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-376000	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	230000	usd
CY2022Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2023Q2	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	250000	usd
CY2022Q2	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	0	usd
CY2023Q2	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	59000	usd
CY2022Q2	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	174000	usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1000	usd
CY2022Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	420000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-177000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-326000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1852000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	974000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2589000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	648000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	737000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	151000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	65000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	648000	usd
CY2023Q2	cyan	Working Capital Deficit WorkingCapitalDeficit	4380000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	974000	usd
CY2023Q1	cyan	Working Capital Deficit WorkingCapitalDeficit	5393000	usd
CY2023Q2	cyan	Long Term Debt And Capital Lease Obligations Current And Noncurrent LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent	3402000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-596000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	91000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5146000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6716000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1736000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1887000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1872000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2049000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6574000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6502000	usd
CY2023Q2	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	324000	usd
CY2023Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	269000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	10506000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	10707000	usd
CY2023Q2	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	133000	usd
CY2022Q2	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	0	usd
CY2023Q2	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	189000	usd
CY2022Q2	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	35000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37182000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37094000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26354000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25947000	usd
CY2023Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	237000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	219000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11065000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11366000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	407000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	417000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	89000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	92000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	5833000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5409000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	89000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	92000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3402000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1000000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	4402000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073	pure
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	203000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	171000	usd
CY2023Q2	cyan	Operating Lease Rightofuse Asset Before Accumulated Amortization OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization	6149000	usd
CY2023Q1	cyan	Operating Lease Rightofuse Asset Before Accumulated Amortization OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization	6149000	usd
CY2023Q2	cyan	Operating Lease Rightofuse Asset Accumulated Amortization OperatingLeaseRightofuseAssetAccumulatedAmortization	1493000	usd
CY2023Q1	cyan	Operating Lease Rightofuse Asset Accumulated Amortization OperatingLeaseRightofuseAssetAccumulatedAmortization	1373000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4656000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4776000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	494000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4146000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4275000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4640000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4758000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	609000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	817000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	794000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	801000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	591000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2854000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6466000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1826000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4640000	usd
CY2023Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	143000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	143000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	79000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	215000	usd
CY2023Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	384000	usd
CY2023Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	393000	usd
CY2023Q2	cyan	Accrued Interest And Legal Liabilities Current AccruedInterestAndLegalLiabilitiesCurrent	47000	usd
CY2023Q1	cyan	Accrued Interest And Legal Liabilities Current AccruedInterestAndLegalLiabilitiesCurrent	30000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	168000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	320000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	821000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1101000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1950000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1079271
CY2023Q2	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Shares Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding	328756
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.88
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.88
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	144666
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.97
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	141667
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.55
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	33333
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.77
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	108334
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.48
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1369000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6290000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-472000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6204000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08

Files In Submission

Name	View Source	Status
0001437749-23-023314-index-headers.html	Edgar Link	pending
0001437749-23-023314-index.html	Edgar Link	pending
0001437749-23-023314.txt	Edgar Link	pending
0001437749-23-023314-xbrl.zip	Edgar Link	pending
cyan-20230630.xsd	Edgar Link	pending
cyan20230630_10q.htm	Edgar Link	pending
ex_553360.htm	Edgar Link	pending
ex_553361.htm	Edgar Link	pending
ex_553362.htm	Edgar Link	pending
ex_553363.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
cyan-20230630_pre.xml	Edgar Link	unprocessable
cyan-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cyan20230630_10q_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cyan-20230630_lab.xml	Edgar Link	unprocessable
cyan-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYAN
CYANOTECH CORP Stock $cyan

2023 Q3 Form 10-Q Financial Statement

#000143774923023314 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYAN CYANOTECH CORP Stock $cyan

2023 Q3 Form 10-Q Financial Statement

#000143774923023314 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYAN
CYANOTECH CORP Stock $cyan